Accelerated assessment in EU for Boehringer's faldaprevir

Boehringer Ingelheim GmbH (Ingelheim, Germany) said EMA granted accelerated assessment to an MAA for faldaprevir ( BI 201335) to treat HCV. Boehringer is seeking approval of faldaprevir in combination...